Suppr超能文献

含苄达明的阴道制剂的摄入。

Ingestions of benzydamine-containing vaginal preparations.

作者信息

Ballesteros Salomé, Ramón Mara Fátima, Martínez-Arrieta Rosa

机构信息

Spanish Poison Control Centre, Instituto de Toxicología y Ciencias Forenses, Madrid, Spain.

出版信息

Clin Toxicol (Phila). 2009 Feb;47(2):145-9. doi: 10.1080/15563650801938670.

Abstract

OBJECTIVE

Benzydamine is a non-steroidal antiinflammatory drug used as vaginal lavage for non-specific vaginitis. Data on overdoses are scarce despite its wide availability.

METHODS

Retrospective analyses of single ingestions of benzydamine vaginal irrigation products from January 1991 to December 2003 reported to the Spanish Poison Control Centre.

RESULTS

724 cases met the inclusion criteria; 86.2% of the patients were over age 14 years. Gender was not a factor in young children but 80.9% of patients older than 14 years were female. In 85.9% of cases, benzydamine was ingested when it was mistaken for an oral preparation or for an oral antiseptic. The rest were unintentional exposures in children (13.8%) or suicidal attempts (0.3%). Clinical signs or symptoms, when present, were mainly gastrointestinal (48% of symptomatic patients) followed by neurological (31%) or both (21%). The most common symptom was nausea (32.8% of symptomatic patients) followed by vomiting (27.9%), dizziness (20.1%), hallucinations (15.3%), abdominal pain (13.4%), and esophageal irritation and agitation (10.5%, each). Six of 68 children (mean age 6.2, range 3-11 years) had hallucinations. A severe case was that of a 4-year-old child who had convulsions caused by the unintentional ingestion of benzydamine.

CONCLUSION

This is the largest report of benzydamine ingestions. The outstanding feature was the high percentage of neurological manifestations in children and adults, mainly hallucinations, following the ingestion of an over-the-counter product.

摘要

目的

苄达明是一种非甾体抗炎药,用作非特异性阴道炎的阴道灌洗剂。尽管其广泛可得,但关于过量用药的数据却很稀少。

方法

对1991年1月至2003年12月间向西班牙中毒控制中心报告的单次摄入苄达明阴道灌洗产品的情况进行回顾性分析。

结果

724例符合纳入标准;86.2%的患者年龄超过14岁。性别在幼儿中不是一个因素,但14岁以上患者中80.9%为女性。在85.9%的病例中,苄达明是在被误认作口服制剂或口服抗菌剂时摄入的。其余为儿童意外接触(13.8%)或自杀未遂(0.3%)。临床体征或症状(若有)主要为胃肠道症状(48%有症状的患者),其次是神经症状(31%)或两者皆有(21%)。最常见的症状是恶心(32.8%有症状的患者),其次是呕吐(27.9%)、头晕(20.1%)、幻觉(15.3%)、腹痛(13.4%)以及食管刺激和激动(各10.5%)。68名儿童中有6名(平均年龄6.2岁,范围3 - 11岁)出现幻觉。有1例严重病例是一名4岁儿童因意外摄入苄达明而惊厥。

结论

这是关于苄达明摄入情况的最大规模报告。突出特点是在摄入一种非处方药后,儿童和成人出现神经症状的比例很高,主要是幻觉。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验